West Pharmaceutical Services, Inc. (WST) Misses Q1 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts WST Hot Sheet
Price: $407.88 -1.15%
Financial Fact:
Income tax expense: 14.4M
Today's EPS Names:
LTBR, AES, SYRS, More
Financial Fact:
Income tax expense: 14.4M
Today's EPS Names:
LTBR, AES, SYRS, More
Join SI Premium – FREE
West Pharmaceutical Services, Inc. (NYSE: WST) reported Q1 EPS of $0.38, $0.03 worse than the analyst estimate of $0.41. Revenue for the quarter came in at $346.8 million versus the consensus estimate of $340.9 million.
For earnings history and earnings-related data on West Pharmaceutical Services, Inc. (WST) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Calix, Inc. (CALX) Tops Q3 EPS by 3c; offers guidance
- Sinda Ltd. (SIND) Reports Q3 Loss of $0.10
- Ryman Hospitality Properties (RHP) Tops Q3 EPS by 15c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
